Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy.

Prajapathi S, Mohta A, Shah B, Pradhan A

DOI: 10.15420/ecr.2026.35
Published: 2026
Container: European cardiology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.15420/ecr.2026.35,
  title = {Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy.},
  author = {Prajapathi S and Mohta A and Shah B and Pradhan A},
  year = {2026},
  journal = {European cardiology},
  doi = {10.15420/ecr.2026.35},
  url = {https://doi.org/10.15420/ecr.2026.35}
}

RIS

TY  - JOUR
TI  - Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy.
AU  - Prajapathi S
AU  - Mohta A
AU  - Shah B
AU  - Pradhan A
PY  - 2026
JO  - European cardiology
DO  - 10.15420/ecr.2026.35
UR  - https://doi.org/10.15420/ecr.2026.35
ER  -

APA

S, P., A, M., B, S., & A, P. (2026). Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy.. European cardiology. https://doi.org/10.15420/ecr.2026.35

Source records

pubmed · retrieved 2026-09-25T08:00:36.983Z